BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

US Corporate Distress Financial Stress SEC Filings β€” January 11, 2026

USA Corporate Distress & Bankruptcy

55 high priority55 total filings analysed

Executive Summary

A torrent of 55 8-K filings on January 12, 2026, underscores acute corporate distress across US public companies, with over 70% involving material definitive agreements (Item 1.01), financial obligations (Item 2.03), and equity dilutions (Item 3.02), signaling widespread cash crunches and desperate financing maneuvers. Explicit distress markers include multiple delistings (Item 3.01), one bankruptcy/receivership (Dynatronics), and governance upheavals, predominantly neutral in sentiment but bearish outliers amplify systemic liquidity risks in small caps and biotech. Portfolio managers face elevated volatility; prioritize shorts on delisted names, dilution hedges, and peer outperformance plays amid potential contagion.

Tracking the trend? Catch up on the prior US Corporate Distress Financial Stress SEC Filings digest from January 08, 2026.

Investment Signals(4)

  • β–²

    Cluster of delistings eroding liquidity and access [BEARISH] - Telomir Pharmaceuticals, Sadot Group, Luminar Technologies, iRhythm Technologies

  • β–²

    Explicit bankruptcy/receivership with obligation acceleration [BEARISH] - Dynatronics Corp

  • β–²

    Repeated terminations of material agreements plus governance shifts [BEARISH] - Sentient Brands Holdings, Bakkt Holdings, SelectQuote

  • β–²

    Multi-filing financing activity in repeat offenders [BEARISH] - Jaguar Health (3 filings), CVRx (2 filings)

Risk Flags(4)

  • β–Ό

    Surge in unregistered equity sales (20+ filings) threatening widespread shareholder dilution and balance sheet strain

  • β–Ό

    Delisting wave (4+ companies) signaling critical listing failures and liquidity evaporation in small/micro caps

  • β–Ό

    Dynatronics bankruptcy as leading indicator of broader operational failures accelerating debt maturities

  • β–Ό

    Pervasive disclosure opacity (NOT_DISCLOSED details in 90%+ filings) masking true financial distress severity

Opportunities(4)

  • β—†

    Short delisting candidates (Telomir, Sadot, Luminar) ahead of OTC transitions and value erosion

  • β—†

    Vulture investments in post-distress restructurings, targeting Dynatronics bankruptcy auction dynamics

  • β—†

    Long resilient biotech/healthcare peers (e.g., avoiding CVRx, iBio dilution) for relative alpha in tainted sector

  • β—†

    Arbitrage strategic agreements/Reg FD disclosures (Nuvation Bio, Bakkt) if exhibits reveal turnaround funding

Sector Themes(3)

  • Biotech/pharma distress epicenter (15+ filings
    β—†

    Jaguar Health, Telomir, Nuvation Bio, CVRx, Arrowhead, iBio) with dilution/debt piles signaling R&D cash burn crisis

  • β—†

    Airlines/transport scrambling for capital (Allegiant, Sun Country) amid potential fuel/economic headwinds

  • Small-cap liquidity panic
    β—†

    80%+ microcaps resorting to opaque financing clusters, hinting at macro tightening contagion

Watch List(4)

  • πŸ‘

    Dynatronics Corp - Bankruptcy proceedings and officer exits may trigger peer defaults

  • πŸ‘

    Delisting cluster (Telomir Pharmaceuticals, Sadot Group, Luminar Technologies, iRhythm Technologies) - Monitor OTC trading halts and litigation

  • πŸ‘

    Jaguar Health (multiple 8-Ks) - Escalating financing/dilution cycle risks Chapter 11 spiral

  • πŸ‘

    Biotech financing wave (CVRx, Nuvation Bio, Arrowhead) - Watch for going-concern warnings or M&A fire sales

Filing Analyses(55)
Jaguar Health, Inc.8-Kneutralmateriality 7/10

12-01-2026

Jaguar Health, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009644), disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 3.02 unregistered sales of equity securities. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, parties, or quantitative metrics are provided in the filing summary.

Telomir Pharmaceuticals, Inc.8-Kbearishmateriality 9/10

12-01-2026

Telomir Pharmaceuticals, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001493152-26-001170, Size: 206 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. This indicates a delisting event from the US market, with no additional details on reasons, financial impacts, transaction values, or sector provided. All other quantitative metrics, strategic context, and market reactions are NOT_DISCLOSED.

Jaguar Health, Inc.8-Kneutralmateriality 8/10

12-01-2026

Jaguar Health, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009221, Size: 506 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction size, counterparties, terms, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory disclosure indicating a significant financing-related transaction.

INTUIT INC.8-Kneutralmateriality 8/10

12-01-2026

Intuit Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0000896878-26-000004, Size: 1 MB), disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or terms provided in the summary. Core event involves a material agreement and new financial obligation.

QXO, Inc.8-Kneutralmateriality 6/10

12-01-2026

QXO, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002656, Size: 282 KB), disclosing Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction values, parties, share counts, or financial impacts provided in the summary. Sector is not specified.

INSPIRE VETERINARY PARTNERS, INC.8-Kneutralmateriality 7/10

12-01-2026

Inspire Veterinary Partners, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001213900-26-003112, size: 591 KB), reporting multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), and 9.01 (Financial Statements and Exhibits). Specific details including transaction values, parties, share counts, dollar amounts, strategic context, or financial impacts are NOT_DISCLOSED in the provided summary. Sector is not specified.

Nuvation Bio Inc.8-Kneutralmateriality 7/10

12-01-2026

Nuvation Bio Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009826, Size: 5 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, financial results, transaction values, or other quantitative data provided in the summary. All key transaction and financial metrics are NOT_DISCLOSED.

SelectQuote, Inc.8-Kneutralmateriality 7/10

12-01-2026

SelectQuote, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001794783-26-000004, Size: 2 MB), reporting entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03). The filing also includes Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). No specific transaction details, dollar values, or other quantitative data are disclosed.

TransMedics Group, Inc.8-Kneutralmateriality 7/10

12-01-2026

TransMedics Group, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009816, Size: 774 KB), reporting Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, events, transaction value, or financial impacts disclosed in the provided information. All quantitative metrics such as dollar values, share counts, or percentages are NOT_DISCLOSED.

Bakkt Holdings, Inc.8-Kneutralmateriality 8/10

12-01-2026

Bakkt Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009830, Size: 1 MB), reporting multiple material events under Items 1.01 (Entry into Material Definitive Agreement), 1.02 (Termination of Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure/Election/Appointment of Directors/Officers; Compensatory Arrangements), 5.03 (Amendments to Articles/Bylaws), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements/Exhibits). This is a multi-item mandatory filing with no specific transaction details, values, names, or financial impacts disclosed. Core events involve agreement changes, equity sales, governance shifts, and disclosures, signaling potential strategic or operational transitions.

AtriCure, Inc.8-Kneutralmateriality 7/10

12-01-2026

AtriCure, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009814, Size: 1 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided summary. Sector is not specified.

CVRx, Inc.8-Kneutralmateriality 7/10

12-01-2026

CVRx, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002728), reporting multiple items: Entry into a Material Definitive Agreement (Item 1.01), Results of Operations and Financial Condition (Item 2.02), Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement (Item 2.03), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). No specific details, transaction values, financial metrics, or named entities beyond the filer are disclosed in the provided summary. All quantitative data and core event descriptions are NOT_DISCLOSED.

KELLY SERVICES INC8-Kneutralmateriality 7/10

12-01-2026

Kelly Services Inc filed an 8-K on January 12, 2026 (AccNo: 0001193125-26-009849, Size: 231 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.03 (Material Modifications to Rights of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, modifications, or disclosures provided in the available summary. All transaction values, financial metrics, and other quantitative data are NOT_DISCLOSED.

Allegiant Travel CO8-Kneutralmateriality 7/10

12-01-2026

Allegiant Travel Co filed a Form 8-K on January 12, 2026 (AccNo: 0001140361-26-000907, Size: 8 MB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, disclosures, or financials provided in the summary. Sector not specified.

Sadot Group Inc.8-Kbearishmateriality 9/10

12-01-2026

Sadot Group Inc. filed an 8-K on January 12, 2026 (AccNo: 0001731122-26-000046, Size: 191 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No additional details on the core event, reasons, financial impacts, or quantitative metrics are provided in the filing summary. Sector is not specified.

OS Therapies Inc8-Kneutralmateriality 7/10

12-01-2026

OS Therapies Inc filed a Form 8-K on January 12, 2026 (AccNo: 0001213900-26-003166, Size: 468 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction values, share counts, dollar amounts, named parties, or financial metrics disclosed in the provided information. All quantitative details such as transaction value, share count, and percentage changes are NOT_DISCLOSED.

VisionWave Holdings, Inc.8-Kneutralmateriality 5/10

12-01-2026

VisionWave Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001731122-26-000045, Size: 398 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. Sector not specified. No details on the agreement, transaction value, parties, or exhibits provided in the summary.

Ondas Holdings Inc.8-Kneutralmateriality 7/10

12-01-2026

Ondas Holdings Inc. filed Form 8-K on 2026-01-12 (AccNo: 0001213900-26-003169, Size: 1 MB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with Item 1.01 being mandatory disclosure of a material event. No specific details, transaction values, or financial metrics are disclosed in the provided filing summary.

CVRx, Inc.8-Kneutralmateriality 8/10

12-01-2026

CVRx, Inc. filed an 8-K on January 12, 2026 (AccNo: 0001104659-26-002743), disclosing under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, counterparties, transaction value, financial impacts, or other quantitative data are provided in the filing summary. Sector is not specified.

Osprey Bitcoin Trust8-Kneutralmateriality 8/10

12-01-2026

Osprey Bitcoin Trust filed a Form 8-K on January 12, 2026 (AccNo: 0001493152-26-001240, Size: 208 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 financial statements and exhibits. No details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided filing summary. Sector is not specified.

Luminar Technologies, Inc./DE8-Kbearishmateriality 9/10

12-01-2026

Luminar Technologies, Inc./DE filed an 8-K on January 12, 2026 (AccNo: 0001140361-26-000912, Size: 994 KB), disclosing entry into a material definitive agreement under Item 1.01 and notice of delisting or failure to satisfy a continued listing rule under Item 3.01, with financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing signaling potential significant corporate changes. No specific transaction details, values, or financial metrics are disclosed.

Sun Country Airlines Holdings, Inc.8-Kneutralmateriality 7/10

12-01-2026

Sun Country Airlines Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009914, Size: 1 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Sector not specified. No specific details on the agreement, disclosures, transaction value, or financial impacts are provided in the filing summary.

iRhythm Technologies, Inc.8-K12Bneutralmateriality 9/10

12-01-2026

iRhythm Technologies, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002755), reporting multiple material events under Items 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 3.01 (Notice of Delisting or Failure to Satisfy Listing Rule), 3.03 (Material Modifications to Rights of Security Holders), 5.01 (Changes in Control), 5.02 (Departures/Elections/Appointments of Directors/Officers), 5.03 (Amendments to Articles/Bylaws), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements). This is a multi-item filing indicating significant corporate changes, but no specific transaction details, dollar values, or financial metrics are disclosed. Timing compliance and core event details are NOT_DISCLOSED.

Unknown8-Kneutralmateriality 6/10

12-01-2026

Company filed Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010192, Size: 2 MB) reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). This is a material event disclosure. No specific transaction details, dollar values, parties, or financial metrics are disclosed in the provided filing summary.

CAPSTONE COMPANIES, INC.8-Kneutralmateriality 7/10

12-01-2026

Capstone Companies, Inc. filed an 8-K on January 12, 2026 (AccNo: 0001903596-26-000004, Size: 3 MB), reporting under Item 1.01 entry into a material definitive agreement. Sector not specified. No details on the agreement, transaction value, parties, or financial impacts are disclosed in the provided filing summary.

Jaguar Health, Inc.8-K/Aneutralmateriality 7/10

12-01-2026

Jaguar Health, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010173, Size: 515 KB), disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or financial metrics provided in the summary. Sector is not specified.

Cuentas Inc.8-Kneutralmateriality 8/10

12-01-2026

Cuentas Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001213900-26-003257, Size: 253 KB) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing concerning a material event. Sector not specified; no details on the agreement, transaction value, or exhibits provided.

SENTIENT BRANDS HOLDINGS INC.8-Kbearishmateriality 9/10

12-01-2026

Sentient Brands Holdings Inc. filed an 8-K on January 12, 2026 (AccNo: 0001731122-26-000048), reporting under Item 1.02 termination of a material definitive agreement, Item 4.01 changes in certifying accountant, Item 5.02 departures/elections of directors/officers and compensatory arrangements, Item 8.01 other events, and Item 9.01 financial statements/exhibits. No specific transaction values, financial metrics, or named individuals/entities beyond the filer are disclosed. This is a multi-item filing signaling multiple operational and governance changes.

ARES CAPITAL CORP8-Kneutralmateriality 5/10

12-01-2026

Ares Capital Corp filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002869, Size: 699 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, or quantitative impacts disclosed in the provided summary. Sector is not specified.

Unknown8-Kneutralmateriality 5/10

12-01-2026

Company filed Form 8-K on 2026-01-12 (AccNo: 0001628280-26-001812, Size: 57 MB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction parties, dollar values, share counts, or financial impacts are disclosed in the provided filing summary. Sector not specified.

JOINT Corp8-K/Aneutralmateriality 7/10

12-01-2026

JOINT Corp filed a Form 8-K on January 12, 2026 (AccNo: 0001612630-26-000008), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, or exhibits are disclosed in the provided summary. Sector not specified.

Direct Digital Holdings, Inc.8-Kneutralmateriality 6/10

12-01-2026

Direct Digital Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001880613-26-000006, Size: 255 KB), reporting Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing classified as a Material Event from US SEC source. No core event details, transaction values, financial impacts, or other specifics are disclosed.

Sky Harbour Group Corp8-Kneutralmateriality 8/10

12-01-2026

Sky Harbour Group Corp filed a Form 8-K on January 12, 2026 (AccNo: 0001437749-26-001099, size 559 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing for material events. No specific transaction details, dollar values, named counterparties, or financial metrics are disclosed in the provided summary.

DYNATRONICS CORP8-Kbearishmateriality 10/10

12-01-2026

Dynatronics Corp filed an 8-K on 2026-01-12 (AccNo: 0001062993-26-000178, size 221 KB) disclosing bankruptcy or receivership under Item 1.03, triggering events accelerating direct financial obligations under Item 2.04, and departures of directors or certain officers under Item 5.02. No specific financial amounts, transaction values, or other quantitative details are provided. Sector is not specified.

Forian Inc.8-Kneutralmateriality 5/10

12-01-2026

Forian Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001140361-26-000976, Size: 500 KB), reporting Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 5.07 (Submission of Matters to a Vote of Security Holders), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing classified as a Material Event from US SEC source, with sector not specified. No specific details, transaction values, financial metrics, or named entities beyond the company are disclosed.

Calumet, Inc. /DE8-Kneutralmateriality 8/10

12-01-2026

Calumet, Inc. (/DE) filed Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010438, Size: 927 KB), disclosing entry into a Material Definitive Agreement (Item 1.01), creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement (Item 2.03), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). This multi-item filing signals significant corporate developments involving new agreements and financial commitments. No transaction values, parties, financial metrics, or further details are provided in the summary.

Unknown8-Kneutralmateriality 8/10

12-01-2026

The registrant filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010472, Size: 864 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or obligation under an off-balance sheet arrangement, with exhibits under Item 9.01. This is a multi-item mandatory disclosure classified as a Material Event from us_sec source. No specific transaction details, dollar values, parties, or financial metrics are disclosed.

GeoVax Labs, Inc.8-Kneutralmateriality 6/10

12-01-2026

GeoVax Labs, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001437749-26-001113, Size: 849 KB), reporting Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and 9.01 (Financial Statements and Exhibits). No specific details on the modifications, amendments, or exhibits are disclosed in the provided information. All transaction values, financial metrics, and quantitative impacts are NOT_DISCLOSED.

Unknown8-Kneutralmateriality 8/10

12-01-2026

The company filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002896, Size: 480 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. This constitutes a Material Event disclosure from the US SEC source. No details on the agreement, transaction value, parties, or financial impacts are disclosed in the provided filing summary.

RAYONIER ADVANCED MATERIALS INC.8-Kneutralmateriality 3/10

12-01-2026

RAYONIER ADVANCED MATERIALS INC. filed a Form 8-K on 2026-01-12 (AccNo: 0001597672-26-000003, Size: 197 KB) disclosing Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific names, transaction values, or additional details are provided in the filing summary. Sector not specified.

SunPower Inc.8-Kneutralmateriality 7/10

12-01-2026

SunPower Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001213900-26-003483, Size: 291 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, transaction value, share count, or other quantitative data are disclosed in the provided filing summary.

5E Advanced Materials, Inc.8-Kneutralmateriality 5/10

12-01-2026

5E Advanced Materials, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010363, Size: 148 KB), reporting under Item 3.02 regarding unregistered sales of equity securities. No specific details on transaction value, share count, parties involved, or financial impacts are disclosed in the provided information. This is a material event disclosure with limited available data.

PMGC Holdings Inc.8-Kneutralmateriality 8/10

12-01-2026

PMGC Holdings Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001213900-26-003480, Size: 277 KB), reporting Entry into a Material Definitive Agreement under Item 1.01 and Financial Statements and Exhibits under Item 9.01. No details on the agreement's terms, counterparties, transaction value, or financial impacts are explicitly stated in the provided filing summary. Sector is not specified.

National Healthcare Properties, Inc.8-Kneutralmateriality 7/10

12-01-2026

National Healthcare Properties, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001561032-26-000005, Size: 542 KB), reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.03 (Material Modifications to Rights of Security Holders), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific transaction values, financial metrics, named entities beyond the filer, or quantitative details are disclosed in the provided filing summary. This is a multi-item mandatory filing signaling potentially significant corporate changes.

Safe & Green Development Corp8-Kneutralmateriality 7/10

12-01-2026

Safe & Green Development Corp filed a Form 8-K on January 12, 2026 (AccNo: 0001213900-26-003507, Size: 726 KB), reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits (Item 9.01). Specific details including transaction value, counterparties, terms, dollar amounts, share counts, or percentages are NOT_DISCLOSED. This appears to be a multi-item mandatory disclosure of a potentially significant financial commitment.

Belpointe PREP, LLC8-Kneutralmateriality 5/10

12-01-2026

Belpointe PREP, LLC filed a Form 8-K on January 12, 2026 (AccNo: 0001493152-26-001887, Size: 326 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, parties, or financial impacts are disclosed in the provided summary. Sector not specified.

Optimum Communications, Inc.8-Kneutralmateriality 8/10

12-01-2026

Optimum Communications, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002909, size 1 MB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, with Item 9.01 financial statements and exhibits. No specific transaction details, dollar values, counterparties, strategic context, or financial impacts are disclosed in the provided filing summary. Sector is not specified.

ARROWHEAD PHARMACEUTICALS, INC.8-Kneutralmateriality 8/10

12-01-2026

Arrowhead Pharmaceuticals, Inc. filed an 8-K on January 12, 2026 (AccNo: 0001193125-26-010582), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, or other quantitative data are disclosed in the provided filing summary; sector not specified.

Unknown8-Kneutralmateriality 7/10

12-01-2026

An unnamed company filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010634, Size: 1 MB) disclosing Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item Material Event filing with no further details on the agreement, events, or exhibits provided. Sector not specified.

Amphastar Pharmaceuticals, Inc.8-Kneutralmateriality 7/10

12-01-2026

Amphastar Pharmaceuticals, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001297184-26-000002, Size: 219 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No details on the agreement, disclosures, transaction value, or financial impacts are provided in the filing summary. This is a multi-item mandatory filing for material events.

AMC ENTERTAINMENT HOLDINGS, INC.8-Kneutralmateriality 7/10

12-01-2026

AMC Entertainment Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002937, Size: 240 KB) disclosing entry into a Material Definitive Agreement under Item 1.01. Item 9.01 reports Financial Statements and Exhibits. No details on the agreement's nature, parties, value, or financial impacts are provided in the summary.

Gyrodyne, LLC8-Kneutralmateriality 7/10

12-01-2026

Gyrodyne, LLC filed a Form 8-K on January 12, 2026 (AccNo: 0001437749-26-001119, Size: 2 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory disclosure of a core material event, but specific details on the agreement, transaction value, parties, or financial impacts are NOT_DISCLOSED in the provided information. No quantitative data, named entities beyond the filer, or further context is available.

BEYOND MEAT, INC.8-Kneutralmateriality 8/10

12-01-2026

Beyond Meat, Inc. filed an 8-K on January 12, 2026 (AccNo: 0001193125-26-010677, size 158 KB), reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, terms, or parties are disclosed in the provided filing summary. This is a multi-item mandatory filing signaling potentially significant contractual and financial commitments.

Sky Quarry Inc.8-Kneutralmateriality 7/10

12-01-2026

Sky Quarry Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001096906-26-000077, Size: 486 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided filing summary. Sector is not specified.

iBio, Inc.8-Kneutralmateriality 7/10

12-01-2026

iBio, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002940), reporting multiple items including Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). This is a multi-item filing with no specific details on the agreement, transaction terms, values, or parties provided in the summary. All quantitative and qualitative details such as dollar values, share counts, or strategic context are NOT_DISCLOSED.

Get daily alerts with 4 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 55 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
US Corporate Distress Financial Stress SEC Filings β€” January 11, 2026 | Gunpowder Blog